CLDX CELLDEX THERAPEUTICS INC Investments/Divestments 8-K Filing 2023 - Underwriting Agreement Celldex Therapeutics, Inc. entered into an underwriting agreement for the offering, issuance, and sale of 7,425,000 shares of common stock at a price of $27.00 per share, with expected net proceeds of approximately $188.3 million.Get access to all SEC 8-K filings of the CELLDEX THERAPEUTICS INC